These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31186846)

  • 21. Chronic hepatitis C infection in children.
    Broide E; Kimchi NA; Scapa E
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):187-93. PubMed ID: 16557189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [IL28B CC genotype: a protective factor and predictor of the response to interferon treatment in chronic hepatitis C virus infection].
    Pár A; Pár G; Tornai I; Szalay F; Várszegi D; Fráter E; Papp M; Lengyel G; Fehér J; Varga M; Gervain J; Schuller J; Nemes Z; Péterfi Z; Tusnádi A; Hunyady B; Haragh A; Szinku Z; Pálinkás L; Berki T; Vincze A; Kisfali P; Melegh B
    Orv Hetil; 2013 Aug; 154(32):1261-8. PubMed ID: 23916907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of Hepatitis B Core-Related Antigen Versus Hepatitis B Surface Antigen and Hepatitis B Virus DNA in Predicting HBeAg-positive and HBeAg-negative Chronic Hepatitis.
    Zhang ZQ; Wang YB; Lu W; Liu DP; Shi BS; Zhang XN; Huang D; Li XF; Zhou XL; Ding RR
    Ann Lab Med; 2019 Jan; 39(1):67-75. PubMed ID: 30215232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus infection: an overview.
    Hwang SJ
    J Microbiol Immunol Infect; 2001 Dec; 34(4):227-34. PubMed ID: 11825001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
    Chu CM; Sheen IS; Liaw YF
    Scand J Gastroenterol; 2004 Aug; 39(8):778-82. PubMed ID: 15513365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sexual transmission of GB virus C/hepatitis G virus.
    Scallan MF; Clutterbuck D; Jarvis LM; Scott GR; Simmonds P
    J Med Virol; 1998 Jul; 55(3):203-8. PubMed ID: 9624607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of liver transplant recipients who have chronic hepatitis C virus infection.
    Korkmaz M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():28-33. PubMed ID: 24635788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of anti-viral therapy for occult hepatitis C virus infection.
    Pardo M; López-Alcorocho JM; Castillo I; Rodríguez-Iñigo E; Perez-Mota A; Carreño V
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1153-9. PubMed ID: 16611276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus genotypes and response to antiviral therapy.
    Enomoto M; Tamori A; Nishiguchi S
    Clin Lab; 2006; 52(1-2):43-7. PubMed ID: 16506363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of pretransplant chronic hepatitis C virus infection treatment on graft and patient survival in renal transplant recipients.
    Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Ensaroğlu F; Selçuk H; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():188-92. PubMed ID: 25894152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alfa therapy.
    Pawlotsky JM; Roudot-Thoraval F; Muerhoff AS; Pellerin M; Germanidis G; Desai SM; Bastie A; Darthuy F; Rémiré J; Zafrani ES; Soussy CJ; Mushahwar IK; Dhumeaux D
    J Med Virol; 1998 Jan; 54(1):26-37. PubMed ID: 9443106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of a single nucleotide polymorphism in the P1 promoter of the furin gene on transcription activity and hepatitis B virus infection.
    Lei RX; Shi H; Peng XM; Zhu YH; Cheng J; Chen GH
    Hepatology; 2009 Sep; 50(3):763-71. PubMed ID: 19492430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter: serum HBcrAg is a useful marker for disease monitoring, predicting treatment response and disease outcome of chronic hepatitis B virus infection.
    Wang ML; Chen EQ; Tao CM; Tang H
    Aliment Pharmacol Ther; 2018 Jun; 47(12):1719-1720. PubMed ID: 29878507
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical significance of TT virus infection in patients with chronic hepatitis C.
    Zein NN; Arslan M; Li H; Charlton MR; Gross JB; Poterucha JJ; Therneau TM; Kolbert CP; Persing DH
    Am J Gastroenterol; 1999 Oct; 94(10):3020-7. PubMed ID: 10520863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C.
    Umemura T; Alter HJ; Tanaka E; Orii K; Yeo AE; Shih JW; Matsumoto A; Yoshizawa K; Kiyosawa K
    Hepatology; 2002 Apr; 35(4):953-9. PubMed ID: 11915044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection.
    Chayama K; Tsubota A; Kobayashi M; Okamoto K; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Suzuki Y; Murashima N; Ikeda K; Kumada H
    Hepatology; 1997 Mar; 25(3):745-9. PubMed ID: 9049229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TT virus infection in patients with chronic hepatitis B or C: influence on clinical, histological and virological features.
    Kao JH; Chen W; Chen PJ; Lai MY; Chen DS
    J Med Virol; 2000 Apr; 60(4):387-92. PubMed ID: 10686020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus reactivation sustained by a hepatitis B virus surface antigen immune-escape mutant isolate in a patient who was hepatitis B core antibody positive during treatment with sofosbuvir and velpatasvir for hepatitis C virus infection: a case report.
    Foroghi Biland L; Ferrari L; Malagnino V; Teti E; Cerva C; Gentile A; Aragri M; Salpini R; Svicher V; Andreoni M; Sarmati L
    J Med Case Rep; 2019 Sep; 13(1):299. PubMed ID: 31542053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control.
    Larrubia JR; Moreno-Cubero E; Miquel J; Sanz-de-Villalobos E
    World J Gastroenterol; 2015 Mar; 21(12):3480-91. PubMed ID: 25834312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter: serum HBcrAg is a useful marker for disease monitoring, predicting treatment response and disease outcome of chronic hepatitis B virus infection-authors' reply.
    Mak LY; Yuen MF
    Aliment Pharmacol Ther; 2018 Jun; 47(12):1720-1721. PubMed ID: 29878508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.